AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 37 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $82,000 | -3.5% | 15,800 | 0.0% | 0.00% | – |
| Q4 2020 | $85,000 | +10.4% | 15,800 | 0.0% | 0.00% | – |
| Q3 2020 | $77,000 | 0.0% | 15,800 | 0.0% | 0.00% | – |
| Q2 2020 | $77,000 | -96.5% | 15,800 | -95.0% | 0.00% | -100.0% |
| Q1 2019 | $2,187,000 | -46.7% | 316,464 | -51.4% | 0.00% | -66.7% |
| Q4 2018 | $4,103,000 | -71.4% | 651,215 | -20.4% | 0.00% | -66.7% |
| Q3 2018 | $14,323,000 | – | 817,992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |